Pulse Biosciences (PLSE)
(Delayed Data from NSDQ)
$14.59 USD
+0.55 (3.92%)
Updated Aug 7, 2024 09:32 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
PLSE 14.59 +0.55(3.92%)
Will PLSE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PLSE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PLSE
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Lags Revenue Estimates
PLSE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PLSE
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
Healthcare 2024 Second Half Outlook
Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX? nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
Pulse Biosciences, Inc. Announces the Closing of its Rights Offering